Start Your NewsReadery Pro FREE TRIAL!
Register and verify your email address to start your
NewsReadery Pro FREE TRIAL
today!
Login / Register
Actions
Newsfeed
Popular
Local
Discover
Follows
Blocks
Bookmarks
Filters
Settings
PowerUps
Help
Updates
Login / Register
investingnews.com
/
Share Newsitem
View, share or embed this newsitem using the details below.
Investing News Network | INN
@investingnews.com
/
1 day
1d
Follow
Results From RMWC Funded Phase II Prostate Cancer Trial using INV043 - Strong Safety Profile and 40% Positive Response Rate
Invion Limited (ASX: IVX) ("Invion" or the "Company") wishes to announce that RMW Cho Group Limited (RMWC), the licensor of the Photosoft technology, has successfully completed a Phase II prostate cancer trial1 (ACTRN12621000633886) using a...
https://newsreadery.com/go/3be9bfc07714edbaf8d424eb7aa00521
Save
Share
Share this Newsitem URL
Embed this Newsitem
<div class="readery-embed readery-embed-3be9bfc07714edbaf8d424eb7aa00521"></div><script async src="https://open.newsreadery.com/oembed?format=html&url=https%3A%2F%2Fnewsreadery.com%2Fitem%2F3be9bfc07714edbaf8d424eb7aa00521" charset="utf-8"></script>
Back
Read Full Article
Continue
Please wait ...